SlideShare a Scribd company logo
1 of 28
Download to read offline
Management of
digitalis toxicity
Dr. Suzan Morsy
Ass. Prof. Clinical Pharmacology, FCMS,
Jeddah KSA
By the end of this session
student should be able to:
• Perform appropriate History taking for a case of
digitalis toxicity
• Perform Clinical examination for a case of
digitalis toxicity
• Determine Investigations used to diagnose
digitalis toxicity
• DescribeTreatment of digitalis toxicity
• The bottle was labelled “digoxin
0.25 mg tablets,” and there were 10
left.
• The Grandmother estimated that
there were probably 40 pills in the
bottle this morning when she took
her usual dose.
• Since the child had been playing
alone for some time, the ingestion
could have occurred anytime within
the past 90 minutes.
A 3-year-old girl is rushed into the Emergency Department carried by her
mother.The mother states that the child just consumed “a bottle of heart pills.”
The mother and the patient were apparently visiting the patient’s grandmother
this afternoon, when the mother discovered her daughter playing in the
bedroom with an open bottle of pills.
Physical
Examination:
• T: 99.4°F
• HR: 40 bpm
• RR: 30 breaths per
minute
• BP: 98/52 mm Hg
• Weight 33 pounds
(15 kg)
• Bedside glucose: 84
• General: Age
appropriate, lethargic
female, whimpering
and whining in the
bed. Responds irritably
to any stimuli.There
are no signs of trauma.
• Pulmonary: Clear to
auscultation.
• CV: Bradycardic,
regular rhythm.
• Initial ECG shows sinus
bradycardia with first
degree AV block.
Digoxin
What are
Predisposing factors
for digitalis toxicity ?
Predisposing factors to digitalis toxicity
Age (elderly and
paediatrics)
Hypokalaemia
Hypercalcemia
Renal impairment
High dose for long
duration
Drugs:
• Drugs causing
hypokalemia (e.g.
furosemide)
• Calcium
What are the cardiac
manifestations of digitalis
toxicity ?
Clinical picture of digitalis toxicity
Cardiac
Bradycardia
Multiple ventricular ectopic beats
Ventricular bigeminy
Atrial tachycardia (with variable block)
Vetricular tachycardia and ventricular fibrillation
ECG for this patient showed
the corresponding figure.
What is your assessment ?
Ventricular ectopic beats.
• There are broad bizarre QRS complexes (arrows)
• with no preceding P wave in between normal sinus beats.
• Their configuration varies,
• so these are multifocal ectopics
What are the Non-cardiac
manifestations of digitalis
toxicity ?
Others
GIT (Nausea, vomiting, abdominal pain,
anorexia, diarrhea)
Ocular
a. Xanthopsia: colored vision, yellow and green patches,
b. Diplopia (Double vision)
c. Scotomata (a partial loss of vision or blind spot in an
otherwise normal visual field)
Neurological: Confusion, lethargy
Skin rash
How to diagnose digitalis
toxicity ?
Diagnosis:
1. History
2. Symptoms and signs
3. Investigations:
a. ECG
b. Plasma digoxin level:
• Therapeutic range
usually 1–2 μg/L
• Concentrations > 4
μg/L usually associated
with toxicity, especially
with chronic poisoning
History
taking for a
patient
treated by
DigoxinTo
identify
early toxicity
A. WIIP
B. Ask about risk factors which increase risk of
digitalis toxicity
1. For how long are you taking digoxin
2. What is the dose of digoxin you are taking?
3. Are you compliant to the dose and the follow up
regimen?
4. Are you taking any other drug (Furosemide,
diuretics)?
5. Are you taking calcium supplements?
6. When was the last time you had renal function test?
Do you have any renal disease?
7. When was the last time your Potassium level in
blood was measured?
C. Ask about
manifestations
of digitalis
overdose
1. Have you felt of any heart-related
symptoms (Palpitation, drowsiness,
dizziness, syncope)
2. Have you felt of any GIT symptoms
((Nausea, vomiting, abdominal pain,
anorexia, diarrhea)
3. Have you experienced eye-related
manifistations
a. Xanthopsia: colored vision, yellow and
green patches
b. Diplopia (Double vision)
c. Scotomata (a partial loss of vision or blind
spot in an otherwise normal visual field)
4. Have you any skin rash or itching?
What are the treatment of
this patient?
Treatment of DigitalisToxicity
1. Airway, Breathing and Circulation management
2. Stop digoxin (and diuretics if patient was receiving diuretics)
3. GIT decontamination: Gastric lavage with repeated doses of activated
charcoal And Cholestyramine
4. Mild toxicity: Potassium sulfate
5. Supraventricular tachyarrhythmias: Propranolol
6. Ventricular tachycardia: Lignocaine, lidocaine or
Phenytoin
7. Severe bradycardia: Atropine
8. Hyperkalaemia: EDTA or Insulin plus Glucose
9. Severe toxicity: DIGIBIND
Is Digibind indicated for
this patient?
What is the dose needed?
Indications of DIGIBIND
1. Life-threatening arrhythmia
2. Hemodynamic instability
3. Severe bradycardia
Dose of Digibind:
• 1 vial of digibind = 40 mg Neutralizes 0.6
mg of digoxine
• No. of digibind vials needed
• = Digoxin level in blood (ng/ml)X wt
(Kg)/100
What are the adverse drug
reactions and contraindications
of Digibind?
Adverse effects of DIGIBIND
1. Allergic reaction
2. Exacerbation of HF
3. Hypokalemia
4. Increase ventricular response to atrial fibrillation and flutter
https://digifab.health/en-us/why-digifab/mechanism-of-action
CONTRAINDICATIONS:
1. Allergy to sheep proteins, papain, papaya extract
Take home message
1. Digoxin can induce acute or chronic toxicity
2. Risk factors for digitalis toxicity include hypokalemia or hypercalcemia, renal
impairment, drugs
3. Therapeutic drug monitoring is essential
4. Manifestations of digitalis toxicity include cardiac, GIT, neurological and skin
manifistations
5. Treatment include supportive therapy, stop further absorption and treatment
of cardiac manifistations
6. DIGIBIND is the antidote for digoxine
Essential readings
1. Casarett & Doull's Essentials ofToxicology. 4th Edition 2021 Mcgraw-Hill.
(https://www.dropbox.com/sh/epbrllqx07wy83t/AACN5rhji5cZ9xmruwuU5zr
sa?dl=0)
2. Biswas Gautam Review of Forensic Medicine andToxicology 4th edition 2018.
Jaypee

More Related Content

Similar to 2)Digitalis toxicity.pdf

Toxicology symposium
Toxicology symposiumToxicology symposium
Toxicology symposium
nswhems
 

Similar to 2)Digitalis toxicity.pdf (20)

DIGITALIS GLYCOSIDE TOXICITY ED management
DIGITALIS GLYCOSIDE TOXICITY ED managementDIGITALIS GLYCOSIDE TOXICITY ED management
DIGITALIS GLYCOSIDE TOXICITY ED management
 
SPM
SPMSPM
SPM
 
Lecture on encephalitis
Lecture on encephalitisLecture on encephalitis
Lecture on encephalitis
 
POISONING emergency for nursing student
POISONING  emergency for nursing studentPOISONING  emergency for nursing student
POISONING emergency for nursing student
 
hypothyroidism.pdf
hypothyroidism.pdfhypothyroidism.pdf
hypothyroidism.pdf
 
Goitre treatment and management accordingly
Goitre treatment and management accordinglyGoitre treatment and management accordingly
Goitre treatment and management accordingly
 
CKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. GawadCKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. Gawad
 
Digitalis
Digitalis Digitalis
Digitalis
 
Pediatric COVID guidelines update.pptx
Pediatric COVID guidelines update.pptxPediatric COVID guidelines update.pptx
Pediatric COVID guidelines update.pptx
 
Approach to patient with unknown overdose
Approach to patient with unknown overdoseApproach to patient with unknown overdose
Approach to patient with unknown overdose
 
Principles of Management of Acute Poisoning
Principles of Management of Acute PoisoningPrinciples of Management of Acute Poisoning
Principles of Management of Acute Poisoning
 
Type 1 Diabetes
Type 1 Diabetes Type 1 Diabetes
Type 1 Diabetes
 
Edited for final
Edited for finalEdited for final
Edited for final
 
Management of COVID 19 in Adults
Management of COVID 19 in AdultsManagement of COVID 19 in Adults
Management of COVID 19 in Adults
 
Covid 19 a cardiologists perspective
Covid 19   a cardiologists perspectiveCovid 19   a cardiologists perspective
Covid 19 a cardiologists perspective
 
Parasitological case study
Parasitological case studyParasitological case study
Parasitological case study
 
Rickettsial disease
Rickettsial diseaseRickettsial disease
Rickettsial disease
 
A CHILD WITH INCOMPLETE KAWASAKI DISEASE (4).pptx
A CHILD WITH INCOMPLETE KAWASAKI DISEASE (4).pptxA CHILD WITH INCOMPLETE KAWASAKI DISEASE (4).pptx
A CHILD WITH INCOMPLETE KAWASAKI DISEASE (4).pptx
 
Toxicology symposium
Toxicology symposiumToxicology symposium
Toxicology symposium
 
NEPHROTIC SYNDROME.pptx1236ygdsdfhjjhtgedsx
NEPHROTIC SYNDROME.pptx1236ygdsdfhjjhtgedsxNEPHROTIC SYNDROME.pptx1236ygdsdfhjjhtgedsx
NEPHROTIC SYNDROME.pptx1236ygdsdfhjjhtgedsx
 

More from AbdulelahMurshid (7)

Developmental-Milestones in children and neonates babies
Developmental-Milestones in children and neonates babiesDevelopmental-Milestones in children and neonates babies
Developmental-Milestones in children and neonates babies
 
2. Respiratory problems in neonates..pdf
2. Respiratory problems in neonates..pdf2. Respiratory problems in neonates..pdf
2. Respiratory problems in neonates..pdf
 
A full description of detailed Surgical _Anatomy_of the abdominal_Wall[1].pdf
A full description of detailed Surgical _Anatomy_of the abdominal_Wall[1].pdfA full description of detailed Surgical _Anatomy_of the abdominal_Wall[1].pdf
A full description of detailed Surgical _Anatomy_of the abdominal_Wall[1].pdf
 
A discription of chest wall trauma in a clinical setting
A discription of chest wall trauma in a clinical settingA discription of chest wall trauma in a clinical setting
A discription of chest wall trauma in a clinical setting
 
Acid Base Balance
Acid Base BalanceAcid Base Balance
Acid Base Balance
 
introduction to Toxicology
introduction to Toxicology introduction to Toxicology
introduction to Toxicology
 
Forensic Autopsy
Forensic Autopsy Forensic Autopsy
Forensic Autopsy
 

Recently uploaded

Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose AcademicsHistology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
claviclebrown44
 
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 QuinolineUnit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
AarishRathnam1
 

Recently uploaded (20)

Face and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptxFace and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptx
 
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas HospitalVaricose Veins Treatment Aftercare Tips by Gokuldas Hospital
Varicose Veins Treatment Aftercare Tips by Gokuldas Hospital
 
ESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failureESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failure
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?
 
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose AcademicsHistology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
 
How to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialHow to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw material
 
Stereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptxStereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptx
 
Hi Fi * Surat ℂall Girls Surat Dumas Road 8527049040 WhatsApp AnyTime Best Su...
Hi Fi * Surat ℂall Girls Surat Dumas Road 8527049040 WhatsApp AnyTime Best Su...Hi Fi * Surat ℂall Girls Surat Dumas Road 8527049040 WhatsApp AnyTime Best Su...
Hi Fi * Surat ℂall Girls Surat Dumas Road 8527049040 WhatsApp AnyTime Best Su...
 
The Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - Subconscious
 
Top 10 Most Beautiful Chinese Pornstars List 2024
Top 10 Most Beautiful Chinese Pornstars List 2024Top 10 Most Beautiful Chinese Pornstars List 2024
Top 10 Most Beautiful Chinese Pornstars List 2024
 
parliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdfparliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdf
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 QuinolineUnit 4 Pharmaceutical Organic Chemisty 3 Quinoline
Unit 4 Pharmaceutical Organic Chemisty 3 Quinoline
 
Anti viral drug pharmacology classification
Anti viral drug pharmacology classificationAnti viral drug pharmacology classification
Anti viral drug pharmacology classification
 
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
 
Benefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdfBenefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdf
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 

2)Digitalis toxicity.pdf

  • 1. Management of digitalis toxicity Dr. Suzan Morsy Ass. Prof. Clinical Pharmacology, FCMS, Jeddah KSA
  • 2. By the end of this session student should be able to: • Perform appropriate History taking for a case of digitalis toxicity • Perform Clinical examination for a case of digitalis toxicity • Determine Investigations used to diagnose digitalis toxicity • DescribeTreatment of digitalis toxicity
  • 3. • The bottle was labelled “digoxin 0.25 mg tablets,” and there were 10 left. • The Grandmother estimated that there were probably 40 pills in the bottle this morning when she took her usual dose. • Since the child had been playing alone for some time, the ingestion could have occurred anytime within the past 90 minutes. A 3-year-old girl is rushed into the Emergency Department carried by her mother.The mother states that the child just consumed “a bottle of heart pills.” The mother and the patient were apparently visiting the patient’s grandmother this afternoon, when the mother discovered her daughter playing in the bedroom with an open bottle of pills.
  • 4. Physical Examination: • T: 99.4°F • HR: 40 bpm • RR: 30 breaths per minute • BP: 98/52 mm Hg • Weight 33 pounds (15 kg) • Bedside glucose: 84 • General: Age appropriate, lethargic female, whimpering and whining in the bed. Responds irritably to any stimuli.There are no signs of trauma. • Pulmonary: Clear to auscultation. • CV: Bradycardic, regular rhythm. • Initial ECG shows sinus bradycardia with first degree AV block.
  • 6. What are Predisposing factors for digitalis toxicity ?
  • 7. Predisposing factors to digitalis toxicity Age (elderly and paediatrics) Hypokalaemia Hypercalcemia Renal impairment High dose for long duration Drugs: • Drugs causing hypokalemia (e.g. furosemide) • Calcium
  • 8. What are the cardiac manifestations of digitalis toxicity ?
  • 9. Clinical picture of digitalis toxicity Cardiac Bradycardia Multiple ventricular ectopic beats Ventricular bigeminy Atrial tachycardia (with variable block) Vetricular tachycardia and ventricular fibrillation
  • 10. ECG for this patient showed the corresponding figure. What is your assessment ?
  • 11. Ventricular ectopic beats. • There are broad bizarre QRS complexes (arrows) • with no preceding P wave in between normal sinus beats. • Their configuration varies, • so these are multifocal ectopics
  • 12.
  • 13. What are the Non-cardiac manifestations of digitalis toxicity ?
  • 14. Others GIT (Nausea, vomiting, abdominal pain, anorexia, diarrhea) Ocular a. Xanthopsia: colored vision, yellow and green patches, b. Diplopia (Double vision) c. Scotomata (a partial loss of vision or blind spot in an otherwise normal visual field) Neurological: Confusion, lethargy Skin rash
  • 15. How to diagnose digitalis toxicity ?
  • 16. Diagnosis: 1. History 2. Symptoms and signs 3. Investigations: a. ECG b. Plasma digoxin level: • Therapeutic range usually 1–2 μg/L • Concentrations > 4 μg/L usually associated with toxicity, especially with chronic poisoning
  • 17. History taking for a patient treated by DigoxinTo identify early toxicity A. WIIP B. Ask about risk factors which increase risk of digitalis toxicity 1. For how long are you taking digoxin 2. What is the dose of digoxin you are taking? 3. Are you compliant to the dose and the follow up regimen? 4. Are you taking any other drug (Furosemide, diuretics)? 5. Are you taking calcium supplements? 6. When was the last time you had renal function test? Do you have any renal disease? 7. When was the last time your Potassium level in blood was measured?
  • 18. C. Ask about manifestations of digitalis overdose 1. Have you felt of any heart-related symptoms (Palpitation, drowsiness, dizziness, syncope) 2. Have you felt of any GIT symptoms ((Nausea, vomiting, abdominal pain, anorexia, diarrhea) 3. Have you experienced eye-related manifistations a. Xanthopsia: colored vision, yellow and green patches b. Diplopia (Double vision) c. Scotomata (a partial loss of vision or blind spot in an otherwise normal visual field) 4. Have you any skin rash or itching?
  • 19.
  • 20. What are the treatment of this patient?
  • 21. Treatment of DigitalisToxicity 1. Airway, Breathing and Circulation management 2. Stop digoxin (and diuretics if patient was receiving diuretics) 3. GIT decontamination: Gastric lavage with repeated doses of activated charcoal And Cholestyramine 4. Mild toxicity: Potassium sulfate 5. Supraventricular tachyarrhythmias: Propranolol
  • 22. 6. Ventricular tachycardia: Lignocaine, lidocaine or Phenytoin 7. Severe bradycardia: Atropine 8. Hyperkalaemia: EDTA or Insulin plus Glucose 9. Severe toxicity: DIGIBIND
  • 23. Is Digibind indicated for this patient? What is the dose needed?
  • 24. Indications of DIGIBIND 1. Life-threatening arrhythmia 2. Hemodynamic instability 3. Severe bradycardia Dose of Digibind: • 1 vial of digibind = 40 mg Neutralizes 0.6 mg of digoxine • No. of digibind vials needed • = Digoxin level in blood (ng/ml)X wt (Kg)/100
  • 25. What are the adverse drug reactions and contraindications of Digibind?
  • 26. Adverse effects of DIGIBIND 1. Allergic reaction 2. Exacerbation of HF 3. Hypokalemia 4. Increase ventricular response to atrial fibrillation and flutter https://digifab.health/en-us/why-digifab/mechanism-of-action CONTRAINDICATIONS: 1. Allergy to sheep proteins, papain, papaya extract
  • 27. Take home message 1. Digoxin can induce acute or chronic toxicity 2. Risk factors for digitalis toxicity include hypokalemia or hypercalcemia, renal impairment, drugs 3. Therapeutic drug monitoring is essential 4. Manifestations of digitalis toxicity include cardiac, GIT, neurological and skin manifistations 5. Treatment include supportive therapy, stop further absorption and treatment of cardiac manifistations 6. DIGIBIND is the antidote for digoxine
  • 28. Essential readings 1. Casarett & Doull's Essentials ofToxicology. 4th Edition 2021 Mcgraw-Hill. (https://www.dropbox.com/sh/epbrllqx07wy83t/AACN5rhji5cZ9xmruwuU5zr sa?dl=0) 2. Biswas Gautam Review of Forensic Medicine andToxicology 4th edition 2018. Jaypee